3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
1
Lung Neoplasms
1
ITCH
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
fexofenadine
1
Prednisone
1
Aprepitant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
ITCH
×
fexofenadine
×
Clear all
NCT01683552
2012-09-12
AprepIt
Campus Bio-Medico University
Phase 2
Completed
45 enrolled